Using mass spectrometry for investigating cancer detection markers and quantifying therapeutic monoclonal antibodies in human plasma
博士 === 國立臺灣大學 === 藥學研究所 === 107 === Cancer is one of the leading causes of death globally. To fight this disease, the researches such as the risk factors of cancer, cancer detection methods, and cancer treatment are all growing rapidly in recent years. Biomarker discovery was one of the potential st...
Main Authors: | Huai-Hsuan Chiu, 邱懷萱 |
---|---|
Other Authors: | 郭錦樺 |
Format: | Others |
Language: | en_US |
Published: |
2018
|
Online Access: | http://ndltd.ncl.edu.tw/handle/9u2b2g |
Similar Items
-
Monoclonal Antibodies as Neurological Therapeutics
by: Panagiotis Gklinos, et al.
Published: (2021-01-01) -
Therapeutic monoclonal antibody for Sporotrichosis
by: Sandro eAlmeida
Published: (2012-11-01) -
Characterization of surface proteins of <it>Cronobacter muytjensii </it>using monoclonal antibodies and MALDI-TOF Mass spectrometry
by: Ababneh Qotaiba O, et al.
Published: (2011-06-01) -
Monoclonal antibodies as potent therapeutics in dentistry.
by: Pratichi Tripathi, et al.
Published: (2019-05-01) -
In vivo characterization of therapeutic monoclonal antibodies
by: Xiaobin Xu
Published: (2016-01-01)